Skip to main content
. 2021 Nov 3;7(5Part B):685–691. doi: 10.1016/j.ijwd.2021.10.015

Table 2.

Concerns regarding SG and interest in prevention or treatment

Pregnant women with SG (n = 116), n (%)
Specific physical concerns regarding SG* Permanency 87 (75)
Discoloration 43 (37)
Discomfort (pain/itching) 26 (22)
Other 4 (3)

Used creams/oils to prevent SG Yes 58 (51)
No 57 (49)

Interest in treatment Yes 23 (20)
Maybe 63 (54)
Unsure 16 (14)
No 14 (12)

Interest in treatment if not covered by insurance Yes 9 (8)
Maybe 29 (25)
Unsure 13 (11)
No 65 (56)

SG = striae gravidarum

Addition of percentages is greater than 100% because participants could choose multiple answers for this question.